溶解性 | Soluble in chloroform, methanol, DMSO (100 mg/ml), water (<1 mg/ml at 25 °C), and ethanol (100 mg/ml). |
存贮条件 | 储存温度-20°C |
应用 | An immunosuppresive inhibitor of FRAP (mTOR). |
产品介绍 | Everolimus (RAD001)是一种mTOR抑制剂,作用于FKBP12,IC50为1.6-2.4 nM。 |
备注 | Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM. |
生化机理 | Everolimus is a macrolide derived from rapamycin with immunosuppressant properties shown to inhibit cell proliferation induced by growth factors. Macrolides belong to a group of antibiotics that bind to the 50S ribosomal subunit and inhibit protein synthesis. Studies indicate that everolimus is a mTOR (FRAP) inhibitor that displays high affinity toward the intracellular receptor FKBP12. Additionally, the Everolimus-FKBP12 complex decreases the activity of the S6K1 and 4EBP by binding to FRAP |
别名 | 依维莫司;RAD001; SDZ-RAD; Certican; Zortress; Afinitor;RAD 001;40-O-(2-Hydroxyethyl)rapamycin; 42-O-(2-Hydroxy)ethyl Rapamycin |
依维莫司
Everolimus (订货以英文为准)
编号:E125341
CAS号:159351-69-6
分子式:C53H83NO14
分子量:958.22
产品名称 | Everolimus |
中文名称 | 依维莫司 |
CAS号 | 159351-69-6 |
分子式(M.F.) | C53H83NO14 |
分子量(M.W.) | 958.22 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品